rs1800625, AGER;PBX2

N. diseases: 39
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.720 0.667 3 2015 2019
Alanine aminotransferase measurement
77 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.700 1.000 1 2016 2016
Drug-induced neutropenia
CUI: C0272178
Disease: Drug-induced neutropenia
54 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.700 1.000 1 2016 2016
Rheumatoid Arthritis
CUI: C0003873
Disease: Rheumatoid Arthritis
2387 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.700 1.000 1 2011 2011
Serum Alanine Aminotransferase Measurement
77 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.700 1.000 1 2016 2016
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.030 1.000 3 2015 2019
Sepsis
CUI: C0243026
Disease: Sepsis
144 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.030 1.000 3 2012 2017
Septicemia
CUI: C0036690
Disease: Septicemia
141 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.030 1.000 3 2012 2017
Carcinogenesis
CUI: C0596263
Disease: Carcinogenesis
355 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2015 2015
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
1204 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2013 2017
Diabetes Mellitus, Non-Insulin-Dependent
2672 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2008 2012
Diabetic Nephropathy
CUI: C0011881
Disease: Diabetic Nephropathy
238 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2012 2017
Diabetic Retinopathy
CUI: C0011884
Disease: Diabetic Retinopathy
213 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2012 2019
Liver carcinoma
CUI: C2239176
Disease: Liver carcinoma
942 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2015 2017
Malignant neoplasm of lung
CUI: C0242379
Disease: Malignant neoplasm of lung
1142 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2013 2017
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 0.500 2 2015 2019
Primary malignant neoplasm of lung
CUI: C1306460
Disease: Primary malignant neoplasm of lung
981 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.020 1.000 2 2013 2017
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
663 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2018 2018
Asthma
CUI: C0004096
Disease: Asthma
1536 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2019 2019
Congestive heart failure
CUI: C0018802
Disease: Congestive heart failure
165 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2012 2012
Coronary Artery Disease
CUI: C1956346
Disease: Coronary Artery Disease
1577 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2013 2013
Gestational Diabetes
CUI: C0085207
Disease: Gestational Diabetes
224 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2010 2010
Heart failure
CUI: C0018801
Disease: Heart failure
201 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2012 2012
Laryngeal Squamous Cell Carcinoma
CUI: C0280324
Disease: Laryngeal Squamous Cell Carcinoma
30 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2019 2019
Left ventricular systolic dysfunction
11 0.641 0.680 6 32184665 upstream gene variant A/G snv 0.15 0.010 1.000 1 2012 2012